Today’s AI Top Pick: BMI

9/15/2026 · Quality Squeeze screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live BMI price forecast →

Today's pick · Quality SqueezeBMIBUY NOW8.2 / 109/15/2026

Badger Meter is the cleanest multi-timeframe setup in this pool. Bullish probability is a max 1.0 with near-term bullish 0.8, and — critically — every relevant timeframe forecast leans positive: 4h fc_short/mid/long +35.7% / +19.3% / +17.8%, 1d +2.5% / +22.3% / +41.9%, and even the 1wk is +10.2% / +17.2% by mid/long. That's the rare quadrant where short, medium, and long horizons all point up at once, which the rubric explicitly rewards. Just as important, BMI is NOT extended. Price at $127.22 sits at just 0% of its 4h 21-bar range, 17.4% on the daily, and 38.7% on the weekly, with a -14.6% drawdown from its weekly 21-bar high. That means we're buying into a consolidation/pullback with the tape forecasting a mean-reversion higher, not chasing a breakout. Compare that to LYFT (100% of 4h range, extended) or SGHC/DLO/LQDA/SEZL where all forecasts are outright negative. Fundamentals fit the quality-squeeze thesis: ROE 18.48%, profit margin 14.27%, debt/equity 0.0 (fortress balance sheet), 15.46% short float providing squeeze fuel, and analyst recom 2.0. The knock is valuation — fwdPE 26.19 and PEG 5.23 aren't cheap — but this is a Consumer-Defensive-like water metering business (recurring, high quality) trading -27% YTD and -28.5% off its 52-week, so the multiple compression is arguably done. News is quiet with no landmines: recent headlines are just a daily dip note and a growth-dividend inclusion; no guidance cut, litigation, or dilution. Why today vs. waiting: the 4h forecast (+35.7% short-horizon) is the strongest immediate signal in the pool for a name that isn't at the top of its range. Waiting risks the base breaking in the wrong direction — the setup is 'pullback into a bullish forecast,' not 'wait for confirmation of a breakout.' CRMD has higher probability but a suspect forward EPS (-87.7%) and weekly forecast rolling over; PSIX has explosive 4h/daily forecasts but a −50% weekly forecast that flatly contradicts them. BMI is the only name where all four dimensions (prob, multi-TF forecast, position-in-range, fundamentals) agree without a fatal contradiction.

Entry zone
$125.50 - $128.00 (buy into the current base; 4h range low)
Stop loss
$117.00 (below the -14.6% weekly drawdown low; ~8% risk)
First target
$140.00 (+10%, retrace half the weekly drawdown, aligns with 4h fc_short)
Longer target
$155.00 - $160.00 (+22-26%, aligns with 1d fc_long +41.9% partial capture and prior range)
Risks
  • Valuation is elevated (fwdPE 26.19, PEG 5.23) — multiple contraction could cap upside even if forecasts play out
  • Sales YoY only +0.8% — growth is anemic for a 26x fwdPE name; any miss compresses hard
  • Stock is already -27.06% YTD and -28.45% 1Y — could be in a persistent downtrend that the forecast is misreading
  • Recent headline noted BMI 'sees a more significant dip than broader market' — potential ongoing distribution
  • Short float 15.46% is the lowest in this quality-squeeze cohort — less squeeze fuel than SEZL (25.8%) or EVER (25.5%)
Honorable mentions
LYFTBullish prob 0.8, near-term 1.0, all three timeframes forecast positive (4h +35.5%, 1d +7.3% mid, 1wk +11.9% mid), and elite fundamentals (PE 2.22, ROE 152.6%, PM 42.3%) plus positive Waymo robotaxi catalyst. Docked to #2 only because 4h position is 100% of range — buy on any pullback to $15.20 instead of chasing.
CRMDBullish prob 1.0, near-term 1.0, 4h forecasts +16-20%, price at just 17-18% of range with -12% drawdown = great tactical entry. Held back from #1 by weekly forecast turning negative (-6% to -8%) and epsNextY estimate of -87.7% plus 'guidance barely budged' headline flagging a forward-earnings risk that contradicts the strong TTM PE of 3.75.
Full ranking (15)
#SymbolVerdictScoreRead
1BMIBUY NOW8.2Multi-TF forecasts all positive, price at bottom of 4h/daily range, prob 1.0, clean news — textbook quality-squeeze entry.
2LYFTBUY PULLBACK7.6Best fundamentals in the pool with Waymo catalyst, but 4h at 100% of range means wait for a dip to ~$15.20.
3CRMDBUY NOW7.3Prob 1.0, near-term 1.0, low in range with -12% drawdown — but forward EPS -87.7% and weak weekly forecast cap conviction.
4PSIXBUY PULLBACK6.8Explosive short/mid forecasts (+65% to +105% on 4h) but weekly fc_long -50% is a serious conflict — size small.
5LRNWAIT5.4Strong fundamentals (PE 11.5, ROE 21.7, +42.9% target upside) but near-term bullish 0.0 and weekly forecast -20% — no rush.
6DUOTWAIT5.0Prob 1.0 and analyst PT raise to $24, but 1wk fc_long -38% and profitMargin 158% is clearly a data anomaly — micro-cap risk.
7TDCWAIT4.8Cheap (PE 6.18, fwdPE 10.09) with ROE 119% but bullish_prob 0.2 and mixed forecasts — value trap risk.
8EVERWAIT4.5PE 7.82 and ROE 53.6% attractive but bullish_prob only 0.2 and all mid/long forecasts negative.
9DUOLAVOID4.31wk pos_in_range 93% (extended), fwdPE 45, and 1d fc_mid -21.5% — chase risk.
10UPWKAVOID4.04h fc +125% is an outlier that should be discounted, and 'Continued Client Losses' headline undercuts the thesis.
11SGHCAVOID3.2Prob 0.0 and all timeframes forecast −20% to −60% despite good fundamentals — tape says no.
12DLOAVOID3.0Prob 0.0, weekly pos 85.7% (extended), and 1d fc_long -16% — sell into strength setup.
13SEZLAVOID2.5Prob 0.4 but 4h fc_short -52.9% and 1d fc_long -34.6% — tape is broken despite +91% YTD.
14PURRAVOID2.3P/S 247.8, single-TF data, and 1d forecasts -10% to -43% after +232% YTD run — parabolic reversal risk.
15LQDAAVOID1.5Weekly forecasts -37% / -69% / -71% and 'LQDA loses 13.9% in a month' headline — do not catch this knife.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.